Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus Epigenetic Randomized Clinical Trial

NCT06533033 is registered in ClinicalTrials.gov with Hams Hamed Abdelrahman as lead sponsor.

NCT NCT06533033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06533033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus Epigenetic Randomized Clinical Trial
Lead sponsor
Hams Hamed Abdelrahman
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2024
Completion date
August 1, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral lichen planus